GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Abbott Laboratories (ABT) [hlAlert]

Rating:
Sell ABT
up 19.74 %

Abbott Laboratories (ABT) downgraded to Sell with price target $52 by Citigroup

Posted on: Friday,  Mar 12, 2010  8:25 AM ET by Citigroup

Citigroup rated Sell Abbott Laboratories (NYSE: ABT) on 03/12/2010, when the stock price was $54.65. Since
then, Abbott Laboratories has lost 16.49% as of 10/07/2015's recent price of $45.64.
If you would have followed this Citigroup's recommendation on ABT, you would have gained 19.74% of your investment in 2035 days.

Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles life itself addressing important health needs from infancy to the golden years.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2010 8:25 AM Sell
None
54.65 52.00
as of 12/31/2010
1 Week down  -0.23 %
1 Month down  -3.03 %
3 Months up  8.26 %
1 YTD up  12.31 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/2/2009 8:25 AM Hold
None
47.16 48.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy